by Vandana Singh | Jan 15, 2026 | General
GT Biopharma Inc. (NASDAQ:GTBP) on Thursday said it submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) in December 2025 for GTB-5550 TriKE for solid tumors. GTB-5550 TriKE is a B7-H3-targeted natural killer (NK) cell...
by Stjepan Kalinic | Jan 15, 2026 | General
President Donald Trump’s intervention in Venezuela has staked the region as the U.S. sphere of influence. While the global media focused on resources like oil, Trump’s move is bigger, and it could undermine China’s ability to expand and maintain its infrastructure....
by Lekha Gupta | Jan 15, 2026 | General
SAP SE ADS (NYSE:SAP) on Thursday disclosed a multi-year strategic technology partnership with agricultural innovation company Syngenta to advance AI-driven innovation across Syngenta’s worldwide operations. Details The partnership will integrate artificial...
by Avi Kapoor | Jan 15, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Goldman Sachs analyst Richard Law downgraded MoonLake...
by Avi Kapoor | Jan 15, 2026 | General
As of Jan. 15, 2026, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its...
by Nabaparna Bhattacharya | Jan 15, 2026 | General
Ericsson (NASDAQ:ERIC) stock climbed in early trading Thursday after the company revealed plans to cut jobs in Sweden. The moves aim to sharpen the telecom gear maker’s competitive edge while protecting its core tech investments. This follows a broader workforce...
Recent Comments